Gastroenterologists Overtake Orthopedic Surgeons as Highest-Paid Physician Recruits, AMN Healthcare Report Finds

AMN Healthcare’s 2026 recruiting review found average physician starting salaries rose to $419,000 from $403,000, while average signing bonuses climbed 29% to $49,306; bonuses were offered in 87% of searches. Gastroenterologists led physician starting salaries at $654,000, while orthopedic surgeons’ average fell 12% to $507,000. The figures reflect competition for specialists in AMN’s 1,293 search engagements from April 2025 through March 2026.

Analysis

The read-through is a demand signal for specialist recruiting, not proof that AMN converts higher offered salaries into higher earnings. If specialist shortages generate more permanent searches and successful placements, AMN could benefit from volume and potentially fee dollars; however, drawn-out searches, client budget limits, or candidates favoring 1099 work could weaken conversion. Salary inflation itself is principally a cost burden for hospitals and medical groups, and may ultimately constrain hiring budgets. AMN’s sample is drawn from its own engagements, so it cannot establish market-wide placement growth or realized compensation.

Near term, the release is a modest positive narrative catalyst for AMN, but not enough on its own to justify a directional position without valuation and operating-trend confirmation. Over 1–3 months, watch AMN’s reported physician/permanent placement revenue, search activity, fill rates, and segment margins. Over 6–18 months, persistent specialist scarcity could support recruiting demand, while wider NP use and contractor arrangements could change which searches AMN can monetize. The high academic-search share matters: lower academic pay can weigh on fee dollars even as search counts remain healthy.

Contrarian point: rising compensation is not unambiguously bullish for healthcare labor intermediaries. If hospitals respond by substituting NPs where clinically feasible, delaying hiring, or shifting to direct/contractor recruitment, scarcity may translate into cost pressure rather than AMN earnings growth. Falsify the constructive thesis if AMN reports weaker physician search conversion or falling relevant revenue/margins despite continued shortage rhetoric.

Key Decisions for Investors

• No standalone trade on the press release. Treat AMN as a watch-list idea; consider a small long only if the stock reaction is muted and subsequent results confirm growth in physician/permanent placement revenue without deterioration in segment margins.
• Over the next 1–3 months, monitor AMN’s search orders, fill/conversion rates, physician placement revenue, and segment margins. Stronger demand without weaker conversion would support the thesis; rising searches paired with poorer conversion would not.
• Track hospital and medical-group hiring restraint, NP substitution, and growth in 1099 arrangements as potential offsets to specialist recruiting demand. Reassess if these trends coincide with lower AMN physician search activity or revenue.
• Avoid inferring broad-market salary growth from this company-generated sample; verify the next report’s scope and AMN’s earnings disclosures before sizing exposure.